A longstanding policy priority for CBSA is supporting our ecosystem’s need for increased access to capital. Through our Capital + Growth efforts, we work closely with public and private partners to accelerate investment in life sciences companies at all stages of commercialization. Critical federal funding sources include the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. These programs are vital for our life sciences community, as they provide early non-dilutive funding to help advance high-risk, early-stage innovative research. As the cost of conducting biomedical research continues to grow, this “first money” becomes increasingly important for attracting additional capital and private investors. In 2019, Colorado companies and organizations received 258 SBIR awards and STTR awards totaling over $82 million dollars.
CBSA Building Momentum Award Announcement Fitzsimons Innovation Community is the inaugural recipient of the Colorado BioScience Association’s new Award: Building Momentum. This award recognizes investments an honoree is making to advance Colorado’s life sciences community […]
Rocky Mountain Life Sciences Investor & Partnering Conference to Welcome More than 200 Attendees Denver – Colorado BioScience Association (CBSA) will highlight the future of health innovation at the Rocky Mountain Life Sciences Investor and […]
Researchers at the University of Colorado Anschutz Medical Campus discovered that while exercise activates muscles, which is critical for bone health, intense exertion over long periods contributes to a metabolic cascade that may lead to […]